CTNM
Price
$12.41
Change
-$0.27 (-2.13%)
Updated
Dec 26 closing price
Capitalization
453.33M
68 days until earnings call
Intraday BUY SELL Signals
TNGX
Price
$8.67
Change
-$0.03 (-0.34%)
Updated
Dec 26 closing price
Capitalization
1.17B
93 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CTNM vs TNGX

Header iconCTNM vs TNGX Comparison
Open Charts CTNM vs TNGXBanner chart's image
Contineum Therapeutics
Price$12.41
Change-$0.27 (-2.13%)
Volume$95.8K
Capitalization453.33M
Tango Therapeutics
Price$8.67
Change-$0.03 (-0.34%)
Volume$1.59M
Capitalization1.17B
CTNM vs TNGX Comparison Chart in %
CTNM
Daily Signal:
Gain/Loss:
TNGX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CTNM vs. TNGX commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTNM is a Hold and TNGX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 27, 2025
Stock price -- (CTNM: $12.41 vs. TNGX: $8.67)
Brand notoriety: CTNM and TNGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTNM: 49% vs. TNGX: 44%
Market capitalization -- CTNM: $453.33M vs. TNGX: $1.17B
CTNM [@Biotechnology] is valued at $453.33M. TNGX’s [@Biotechnology] market capitalization is $1.17B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTNM’s FA Score shows that 1 FA rating(s) are green whileTNGX’s FA Score has 0 green FA rating(s).

  • CTNM’s FA Score: 1 green, 4 red.
  • TNGX’s FA Score: 0 green, 5 red.
According to our system of comparison, both CTNM and TNGX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTNM’s TA Score shows that 6 TA indicator(s) are bullish while TNGX’s TA Score has 3 bullish TA indicator(s).

  • CTNM’s TA Score: 6 bullish, 4 bearish.
  • TNGX’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, CTNM is a better buy in the short-term than TNGX.

Price Growth

CTNM (@Biotechnology) experienced а +5.71% price change this week, while TNGX (@Biotechnology) price change was +1.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.36%. For the same industry, the average monthly price growth was +0.27%, and the average quarterly price growth was +54.56%.

Reported Earning Dates

CTNM is expected to report earnings on Mar 05, 2026.

TNGX is expected to report earnings on Mar 30, 2026.

Industries' Descriptions

@Biotechnology (+0.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TNGX($1.17B) has a higher market cap than CTNM($453M). TNGX YTD gains are higher at: 180.583 vs. CTNM (-15.290). CTNM has higher annual earnings (EBITDA): -59.04M vs. TNGX (-107.91M). CTNM has more cash in the bank: 182M vs. TNGX (153M). CTNM has less debt than TNGX: CTNM (5.49M) vs TNGX (34.8M). TNGX has higher revenues than CTNM: TNGX (66.5M) vs CTNM (0).
CTNMTNGXCTNM / TNGX
Capitalization453M1.17B39%
EBITDA-59.04M-107.91M55%
Gain YTD-15.290180.583-8%
P/E Ratio26.40N/A-
Revenue066.5M-
Total Cash182M153M119%
Total Debt5.49M34.8M16%
TECHNICAL ANALYSIS
Technical Analysis
CTNMTNGX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 10 days ago
87%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CTNM
Daily Signal:
Gain/Loss:
TNGX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WTMVX11.960.01
+0.08%
Segall Bryant & Hamill Glb All Cp Retail
TCMGX19.320.01
+0.05%
Nuveen Quant Mid Cap Growth A
BRLVX25.58N/A
N/A
American Beacon Man Lg Cp Value R5
JVAAX36.56-0.01
-0.03%
JPMorgan Value Advantage A
HISVX42.01-0.04
-0.10%
Harbor Small Cap Value Investor

CTNM and

Correlation & Price change

A.I.dvisor tells us that CTNM and VYGR have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTNM and VYGR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTNM
1D Price
Change %
CTNM100%
-2.13%
VYGR - CTNM
29%
Poorly correlated
+0.25%
CCCC - CTNM
28%
Poorly correlated
+1.92%
TNGX - CTNM
28%
Poorly correlated
-0.34%
MREO - CTNM
27%
Poorly correlated
+0.43%
SLN - CTNM
27%
Poorly correlated
+0.98%
More

TNGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNGX has been loosely correlated with CLDX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if TNGX jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNGX
1D Price
Change %
TNGX100%
-0.34%
CLDX - TNGX
44%
Loosely correlated
-1.60%
XNCR - TNGX
44%
Loosely correlated
-1.49%
NGNE - TNGX
43%
Loosely correlated
-0.30%
FDMT - TNGX
42%
Loosely correlated
-1.60%
AXON - TNGX
41%
Loosely correlated
-1.24%
More